Notice: Prescription Drug List (PDL): Ibuprofen

August 18, 2016
Our file number: 16-109277-453

The purpose of this Notice of Amendment is to notify that Health Canada will switch certain uses of Ibuprofen to nonprescription status for human use by modifying the Human Prescription Drug List (PDL). The Veterinary List will remain unchanged. Health Canada has conducted a scientific review of Ibuprofen against a set of established and publicly available criteria outlined in section C.01.040.3 of the Food and Drug Regulations. The listing now reads:

Drugs containing the following: Ibuprofen or its salts

Qualifier: except:

1. An oral dosage form that provides 400 milligrams or less per dosage unit; or
2. A modified-release oral dosage form that provides 600 milligrams or less per dosage unit.

Effective Date: Date of this Notice

Should you have any questions on this update to the Prescription Drug List, please contact:

Prescription Drug Status Committee
Health Canada
Holland Cross, Tower B, 2nd Floor
1600 Scott Street
Address Locator 3102C3
Ottawa, Ontario
K1A 0K9

Email: drug_prescription_status-statut_d'ordonnance_des_drogues@hc-sc.gc.ca
Telephone: 613-957-1058
Telecopier: 613-941-1812